You are here

  • Home
  • Archive
  • Volume 18, Issue 5
  • Primary clear cell adenocarcinoma of the rectovaginal septum treated with concurrent chemoradiation therapy: a case report

Article Text

Article menu
Download PDFPDF
CORRESPONDENCE AND BRIEF REPORTS
Primary clear cell adenocarcinoma of the rectovaginal septum treated with concurrent chemoradiation therapy: a case report
  1. M. Guiou*,
  2. W. H. Hall*,
  3. T. Konia†,
  4. S. Scudder‡,
  5. G. Leiserowitz§ and
  6. J. K. Ryu*
  1. * Department of Radiation Oncology,
  2. † Department of Pathology,
  3. ‡ Division of Hematology and Oncology, Department of Internal Medicine, and
  4. § Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, UC Davis Health System, Sacramento, California
  1. Address correspondence and reprint requests to: William H. Hall, MD, Department of Radiation Oncology, UC Davis Health System, 4501 X Street, Suite 0140, Sacramento, CA 95817, USA. Email: william.hall{at}ucdmc.ucdavis.edu

Abstract

Primary clear cell adenocarcinoma of the rectovaginal septum is rare and typically emerges in the setting of endometriosis. We report a case of a 52-year-old woman with clear cell adenocarcinoma of the rectovaginal septum presenting with vaginal hemorrhage. Management with concurrent chemoradiation with cisplatin and paclitaxel is discussed. Six years following the completion of treatment, the patient is without evidence of disease or significant long-term toxicity

  • chemoradiation
  • clear cell
  • rectovaginal septum

https://doi.org/10.1111/j.1525-1438.2007.01124.x

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.